NCIt definition : An orally bioavailable tyrosine kinase inhibitor of the BCR-ABL fusion oncoprotein,
with potential antineoplastic activity. Upon oral administration, BCR-ABL tyrosine
kinase inhibitor BL001 may inhibit the BCL-ABL protein, which may lead to decreased
proliferation and enhanced apoptosis in tumor cells. BCR-ABL oncoprotein is generated
by a reciprocal translocation between chromosome 9 and 22 specifically t(9;22)(q34;q11).
The resulting fusion gene produces proteins with constitutively active tyrosine kinase
activity, which stimulate both abnormal cell division and increased cellular proliferation.
This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic
leukemia.;